✦ LIBER ✦

Sorafenib worthy of further investigation in thyroid cancer

Book ID: 120843447
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816470-00024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sorafenib a worthy opponent for advanced

Sorafenib a worthy opponent for advanced renal cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Sorafenib: Rays of Hope in Thyroid Cance

Sorafenib: Rays of Hope in Thyroid Cancer

✍ Duntas, Leonidas H.; Bernardini, Renato 📂 Article 📅 2010 🏛 Mary Ann Liebert 🌐 English ⚖ 222 KB

Sorafenib in thyroid cancer—a retrospect

Sorafenib in thyroid cancer—a retrospective case series

✍ Gamerith, Gabriele; Pircher, Andreas; Amann, Arno; Cima, Katharina; Gasser, Klau 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 789 KB

Phase II Trial of Sorafenib in Advanced

Phase II Trial of Sorafenib in Advanced Thyroid Cancer

✍ Gupta-Abramson, V.; Troxel, A. B.; Nellore, A.; Puttaswamy, K.; Redlinger, M.; R 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 281 KB

Understanding the Mechanism of Late Sora

Understanding the Mechanism of Late Sorafenib Failure in Metastatic Thyroid Cancer

✍ Marc A Cohen; Changqing Ma; Yan Wang; Waixing Tang; Jeffrey E Olson; Marcia S Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Phase II Clinical Trial of Sorafenib in

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

✍ Lam, E. T.; Ringel, M. D.; Kloos, R. T.; Prior, T. W.; Knopp, M. V.; Liang, J.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB